Raymond Debbane - May 21, 2023 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
Director
Signature
/s/ Raymond Debbane
Stock symbol
LXRX
Transactions as of
May 21, 2023
Transactions value $
$0
Form type
4
Date filed
5/22/2023, 04:03 PM
Previous filing
May 11, 2023
Next filing
Oct 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise $0 +9.3K +2.81% $0.00 341K May 21, 2023 Direct
holding LXRX Common Stock 5.45M May 21, 2023 By Invus US Partners LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise $0 -9.3K -100% $0.00* 0 May 21, 2023 Common Stock 9.3K $0.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.